Ohio State University Comprehensive Cancer Center: Carcinoma trials

The registry lists 23 Carcinoma studies with Ohio State University Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 1 5Phase 2 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerCompletedNCT05086705Not applicableResults posted
• Resiliency Among Older Adults Receiving Lung Cancer TreatmentCompletedNCT04229381Not applicableResults posted
• Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungWithdrawnNCT05412875Not applicable
• Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung CancerCompletedNCT05304793Not applicable
• An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsCompletedNCT05012176Not applicable
• Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL StudyCompletedNCT04267874Early Phase 1
• Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal CancerWithdrawnNCT04140513Not applicable
• Nipple Aspirate Fluid in Detecting Breast CancerCompletedNCT03715959Not applicable
• Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation TherapyWithdrawnNCT03611205Not applicable
• Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants with Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT03552471Phase 1
• Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer SurvivorsCompletedNCT03372720Not applicable
• Fractional CO2 Laser Therapy for Survivors of Breast MalignanciesCompletedNCT03307044Not applicable
• Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT02507765Phase 1
• Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT02072356Early Phase 1
• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
• Pilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerCompletedNCT01975363Not applicable
• Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental CareCompletedNCT01816841Not applicable
• Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
• Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
• Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast CancerWithdrawnNCT01729832Not applicable
• Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsCompletedNCT01504932Not applicable
• Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
• Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell CarcinomaCompletedNCT01064921Phase 1